The Vanguard Group 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX | The Vanguard Group | 3,877,339 7.840% | 436,879 (+12.70%) | Filing |
| 2021-02-10 11:57 am Purchase | 2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX | The Vanguard Group | 3,440,460 7.140% | 1,475,226 (+75.07%) | Filing |